…at 1 point last week, the DJIA was down 38% from its highs in February. Now, on Tuesday the last day of trading for Q-1 of Y 2020, the DJIA was down about 22% YTD.
Today, looking the leaders of the DJIA the following are the 5 best performers for the Bear Quarter.
Consensus price target data and other consensus items are from Refinitiv.
Microsoft Corp. (NASDAQ:MSFT) led with a YTD gainer of 1.6%. Despite warning that PC software sales would be weak, this is “all about the cloud,” and businesses are perhaps migrating to the cloud even more with so many workers having to work remotely. Microsoft stock was trading at 157.71, and its consensus target price was at 189.35 last look.
Walmart Inc. (NYSE:WMT) is the 2nd Top stock, though it was down 3% so far in Y 2020. Walmart is one of the “essential businesses” that has pledged to remain open during the COVID-19 pandemic. The retail giant’s shares have been volatile over the past month, but Walmart is touted as a recession-proof stock now. The consumer buying habits are grossly different in the past 40 days than they had been for years, and that will make it hard to know how the sales fare overall compared with prior Quarters, despite all the mass buying and hoarding. Trading at 113.62, Walmart has a consensus target price is at 130.03.
Intel Corp. (NASDAQ:INTC) has tech exposure to PCs, but its server business is still strong, and Intel’s supply chain seemed to see less impact than some other chip companies. Intel is down 7% YTD, and at 54.12 it is down 21% from its 52-wk high. The consensus target price is at 62.58.
Procter & Gamble Co. (NYSE:PG) is defensive in consumer products. Its shares were not immune as people just are not able to buy as much of their products or do not need them while sequestered at home. P&G shares were down less than 8% YTD into the last day of the Quarter. Shares were trading at 110 at the close, and the consensus target price is at 126.06. The dividend yield is now close to 2.6%, the stock is down 13% from its recent highs.
Johnson & Johnson (NYSE:JNJ) is also defensive by nature, in consumer products, pharmaceuticals and medical. It was down 8.8% so far in 2020 coming into the last day of the first quarter. This is one company in the race to develop a vaccine or treatment for COVID-19 as well, and many of its products should still be selling well. The stock was still down 15% from its high at the start of February, but trading at 131.13, its dividend yield is above 2.8%. The consensus target price is at 159.18.
Have a healthy day, stay home!